Metformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology
Link
http://www.nature.com/articles/oncsis201518.pdf
Reference37 articles.
1. Clyne M . Metformin—the new wonder drug? Nat Rev 2014; 2014: 366.
2. Pollak M . Potential applications for biguanides in oncology. J Clin Invest 2013; 123: 3693–3700.
3. Thompson AM . Molecular pathways: preclinical models and clinical trials with metformin in breast cancer. Clin Cancer Res 2014; 20: 2508–2515.
4. Janzer A, German NJ, Gonzalez-Herrera KN, Asara JM, Haigis MC, Struhl K . Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells. Proc Natl Acad Sci USA 2014; 111: 10574–10579.
5. Kasinski AL, Slack FJ . Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11: 849–864.
Cited by 83 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Neuronatin Promotes the Progression of Non-small Cell Lung Cancer by Activating the NF-κB Signaling;Current Cancer Drug Targets;2024-11
2. Metformin and its potential influence on cell fate decision between apoptosis and senescence in cancer, with a special emphasis on glioblastoma;Frontiers in Oncology;2024-08-29
3. Metformin: A Dual-Role Player in Cancer Treatment and Prevention;International Journal of Molecular Sciences;2024-04-06
4. Early life stress-induced miR-708-5p regulates mood disorder-associated behavioural phenotypes in mice and is a potential diagnostic biomarker for bipolar disorder;2024-03-14
5. Immunohistochemical evidences of anticancer actions of metformin with other repurposed drug combinations and correlation with hamster fibrosarcoma tumor size;Journal of the Serbian Chemical Society;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3